Nexien BioPharma Inc.

Nexien BioPharma is proceeding with pre-clinical and clinical drug development activities, in accordance with U.S. Food and Drug Administration (`FDA`) protocols, for a number of pharmaceutical formulations that include cannabinoids. Nexien BioPharma operates in strict compliance with United States Drug Enforcement Administration (DEA) licensed pharmaceutical clinical research organizations (CRO`s), contract manufacturing partners (CDMO`s), and prestigious academic research institutions.